 |
Top 10 Skin Cancer and Melanoma treatment startups in USA
Updated: May 01, 2024 |
1
Funding: $1.6B
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
2
Funding: $259.9M
DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.
DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.
3
Funding: $218.5M
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
4
Funding: $170M
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
5
Funding: $165M
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
6
Funding: $34.6M
DermaSensor is developing a medical device that aims to detect the risk of skin cancer.
DermaSensor is developing a medical device that aims to detect the risk of skin cancer.
7
Funding: $34.3M
Viewpoint Molecular Targeting develops pharmaceutical drugs for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. Our novel image-guided therapies enable a personalized approach to select patients that can benefit most and to optimize treatment planning for our targeted therapies.
Viewpoint Molecular Targeting develops pharmaceutical drugs for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. Our novel image-guided therapies enable a personalized approach to select patients that can benefit most and to optimize treatment planning for our targeted therapies.
8
Funding: $25M
Sensus Healthcare is focused on developing proven non-invasive treatment for non-melanoma skin cancer.
Sensus Healthcare is focused on developing proven non-invasive treatment for non-melanoma skin cancer.
9
Funding: $6.8M
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.
10
Funding: $3.4M
SkinIO is helping people prevent skin cancer by providing a service that allows them to regularly monitor their skin with the help of artificial intelligence and licensed dermatologists. Users can take photos with their smartphone of their skin and lesions, and upload them to a database through SkinIO’s app.
SkinIO is helping people prevent skin cancer by providing a service that allows them to regularly monitor their skin with the help of artificial intelligence and licensed dermatologists. Users can take photos with their smartphone of their skin and lesions, and upload them to a database through SkinIO’s app.
Ad
Advertise your startup
11
Funding: $120K
Constellation is changing the way the world sees skin cancer. Their imaging system provides full-body skin mapping and ongoing monitoring. Lightweight, affordable, and convenient.
Constellation is changing the way the world sees skin cancer. Their imaging system provides full-body skin mapping and ongoing monitoring. Lightweight, affordable, and convenient.
12
MCR Therapeutics developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery. The peptides, which are specific for certain melanocortin receptors, represent a leap forward in novel options for skin cancer prevention, detection and treatment.